Zydus Cadila gets USFDA nod for leukemia treatment injection

New Delhi: Zydus Cadila Wednesday said it has received approval from the US health regulator to market Arsenic Trioxide injection, used to treat a type of leukemia. Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Arsenic Trioxide injection, 10 mg/10 mL (1 mg/mL) single-dose vial, the company said in a BSE filing.

Arsenic Trioxide is used to treat a type of leukemia (acute promyelocytic leukemia-APL) when other types of treatment (such as chemotherapy) have not worked well or no longer work, it added.

Zydus Cadila said the drug will be manufactured at Alidac Pharmaceuticals, the company’s wholly-owned subsidiary located at special economic zone (SEZ), Ahmedabad.

The group has more than 228 approvals, and so far filed over 330 abbreviated new drug applications (ANDAs) since it started filings in 2003-04.

Shares of Cadila Healthcare, the listed entity of the group, were trading 3.46 per cent higher at Rs 367.85 apiece on BSE.

  • Related Posts

    3-month relief: Final call for 10,000 pharmacists to renew registration

    At least 70,000 pharmacists are registered in Haryana; of these, about 10,000 — whose registrations expired on December 31, 2020, — have not yet renewed The Haryana State Pharmacy Council…

    Marksans Pharma gets USFDA nod for generic Benzonatate capsules

    Marksans Pharma Ltd on Wednesday said it has received final approval from the US health regulator for its generic version of Benzonatate capsules indicated for treatment of persistent cough, bronchitis,…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    3-month relief: Final call for 10,000 pharmacists to renew registration

    3-month relief: Final call for 10,000 pharmacists to renew registration

    Marksans Pharma gets USFDA nod for generic Benzonatate capsules

    Marksans Pharma gets USFDA nod for generic Benzonatate capsules

    Greatest Defender of Consumer Rights doesn’t like Sound of Patient as ‘GRAHAK’

    Greatest Defender of Consumer Rights doesn’t like Sound of Patient as ‘GRAHAK’

    Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test

    Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test

    Haryana Mandates Real-Time Medicine Tracking In Govt Hospitals

    Haryana Mandates Real-Time Medicine Tracking In Govt Hospitals

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices